Connection

PAUL KLOTMAN to Disease Models, Animal

This is a "connection" page, showing publications PAUL KLOTMAN has written about Disease Models, Animal.
Connection Strength

0.551
  1. Transgenic and infectious animal models of HIV-associated nephropathy. J Am Soc Nephrol. 2009 Nov; 20(11):2296-304.
    View in: PubMed
    Score: 0.138
  2. Nephropathy in HIV-transgenic mice. Contrib Nephrol. 1994; 107:194-204.
    View in: PubMed
    Score: 0.047
  3. Glomerular MYH9 expression is reduced by HIV-1. AIDS. 2012 Apr 24; 26(7):797-803.
    View in: PubMed
    Score: 0.042
  4. HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells. Kidney Int. 2008 Oct; 74(8):1049-58.
    View in: PubMed
    Score: 0.032
  5. HIV-associated nephropathy. Contrib Nephrol. 2008; 159:151-161.
    View in: PubMed
    Score: 0.031
  6. HIV-1 and HIV-Associated Nephropathy 25 Years Later. Clin J Am Soc Nephrol. 2007 Jul; 2 Suppl 1:S20-4.
    View in: PubMed
    Score: 0.030
  7. Tubular-specific expression of HIV protein Vpr leads to severe tubulointerstitial damage accompanied by progressive fibrosis and cystic development. Kidney Int. 2023 03; 103(3):529-543.
    View in: PubMed
    Score: 0.022
  8. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int. 2000 Jul; 58(1):173-81.
    View in: PubMed
    Score: 0.019
  9. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lab Invest. 2000 Feb; 80(2):187-97.
    View in: PubMed
    Score: 0.018
  10. Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury. Kidney Int. 2018 12; 94(6):1160-1176.
    View in: PubMed
    Score: 0.017
  11. Mitochondrial dysfunction in human immunodeficiency virus-1 transgenic mouse cardiac myocytes. J Cell Physiol. 2019 04; 234(4):4432-4444.
    View in: PubMed
    Score: 0.016
  12. Pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy. Semin Nephrol. 1998 Jul; 18(4):436-45.
    View in: PubMed
    Score: 0.016
  13. Transgenic models of human immunodeficiency virus type-1. Curr Top Microbiol Immunol. 1996; 206:197-222.
    View in: PubMed
    Score: 0.014
  14. Transgenic models of HIV-1. AIDS. 1995 Apr; 9(4):313-24.
    View in: PubMed
    Score: 0.013
  15. Maternal-fetal interactions affect growth of human immunodeficiency virus type 1 transgenic mice. Pediatr Res. 1995 Jan; 37(1):56-63.
    View in: PubMed
    Score: 0.013
  16. bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney Int. 1994 Sep; 46(3):759-72.
    View in: PubMed
    Score: 0.012
  17. Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy. AIDS. 2013 Apr 24; 27(7):1091-8.
    View in: PubMed
    Score: 0.011
  18. Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy. Am J Physiol Renal Physiol. 2013 Apr 15; 304(8):F1127-36.
    View in: PubMed
    Score: 0.011
  19. Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure. Kidney Int. 2012 May; 81(9):856-64.
    View in: PubMed
    Score: 0.010
  20. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol. 2011 Nov; 22(11):1991-6.
    View in: PubMed
    Score: 0.010
  21. Role of the retinoic acid receptor-a in HIV-associated nephropathy. Kidney Int. 2011 Mar; 79(6):624-634.
    View in: PubMed
    Score: 0.010
  22. HIV type-1 transgene expression in mice alters adipose tissue and adipokine levels: towards a rodent model of HIV type-1 lipodystrophy. Antivir Ther. 2010; 15(7):1021-8.
    View in: PubMed
    Score: 0.009
  23. HIV-1 Vpr activates the DNA damage response in renal tubule epithelial cells. AIDS. 2009 Sep 24; 23(15):2054-6.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.